Induction and Concurrent Taxanes Enhance Both the Pulmonary Metabolic Radiation Response and the Radiation Pneumonitis Response in Patients With Esophagus Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3, 2010, Pages 816-823

  McCurdy, Matthew ^a,b   McAleer, Mary Frances ^a   Wei, Wei ^b   Ezhil, Muthuveni ^a   Johnson, Valen ^a   Khan, Meena ^a   Baker, Jamie ^a   Luo, Dershan ^a   Ajani, Jaffer ^a   Guerrero, Thomas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

positron emission tomography; Radiation pneumonitis; taxanes

Indexed keywords

ADVERSE EVENTS; ANDERSONS; CHEMORADIOTHERAPY; COMMON TERMINOLOGY CRITERIA; CONCURRENT CHEMOTHERAPY; CONFIDENCE INTERVAL; ENHANCEMENT RATIOS; ESOPHAGEAL CANCER; ESOPHAGUS CANCER; F-FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE; NATIONAL CANCER INSTITUTE; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES; PULMONARY TOXICITY; RADIATION DOSE; RADIATION PNEUMONITIS; RADIATION RESPONSE; RADIATION TOXICITY; TAXANES; UNIVERSITY OF TEXAS;

CHEMOTHERAPY; DRUG PRODUCTS; METABOLISM; PATIENT MONITORING; POSITRONS; RADIATION; RADIOTHERAPY; REGRESSION ANALYSIS; TOXICITY;

POSITRON EMISSION TOMOGRAPHY;

5 CHLORO 2,4 DIHYDROXYPYRIDINE; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; EPIRUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; IRINOTECAN; OXALIPLATIN; OXONIC ACID; PACLITAXEL; PROTEIN BCL 2 INHIBITOR; TEGAFUR; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG UPTAKE; ESOPHAGUS CANCER; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; RADIATION RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIATION PNEUMONITIS; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TAXOIDS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 76049116316     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.059     Document Type: Article

References (40)

1. Rowinsky E.K. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 48 (1997) 353-374
2. Pazdur R., Kudelka A.P., Kavanagh J.J., et al. The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere). Cancer Treat Rev 19 (1993) 351-386
3. Ajani J.A., Ilson D.H., Daugherty K., et al. Activity of Taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 86 (1994) 1086-1091
4. Beal K., Hudis C., Norton L., et al. Radiation pneumonitis in breast cancer patients treated with taxanes: Does sequential radiation therapy lower the risk?. Breast J 11 (2005) 317-320
5. Weiss R.B., Donehower R.C., Wiernik P.H., et al. Hypersensitivity reactions from Taxol. J Clin Oncol 8 (1990) 1263-1268
6. Sekine I., Nishiwaki Y., Watanabe K., et al. Phase II study of 3-hour infusion of paclitaxel in previously untreated non-small cell lung cancer. Clin Cancer Res 2 (1996) 941-945
7. Ghafoori P., Marks L.B., Vujaskovic Z., et al. Radiation-induced lung injury assessment, management, and prevention. Oncology (Huntingt) 22 (2008) 37-47
8. Taghian A.G., Assaad S.I., Niemierko A., et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 93 (2001) 1806-1811
9. Hanna Y.M., Baglan K.L., Stromberg J.S., et al. Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy. Breast J 8 (2002) 149-153
10. Taghian A.G., Assaad S.I., Niemierko A., et al. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?. Int J Radiat Oncol Biol Phys 62 (2005) 386-391
11. Yu T.K., Whitman G.J., Thames H.D., et al. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. J. Natl Cancer Inst 96 (2004) 1676-1681
12. Movsas B., Chetty I., and Ajlouni M. Can patient reporting affect radiation pneumonitis?. Oncology (Huntingt) 22 (2008) 52-53
13. Roberts C.M., Foulcher E., Zaunders J.J., et al. Radiation pneumonitis: A possible lymphocyte-mediated hypersensitivity reaction. Ann Intern Med 118 (1993) 696-700
14. Fajardo L.F., Berthrong M., and Anderson R.E. Radiation pathology (2001), Oxford University Press, New York
15. Chen D.L., Rosenbluth D.B., Mintun M.A., et al. FDG-PET imaging of pulmonary inflammation in healthy volunteers after airway instillation of endotoxin. J Appl Physiol 100 (2006) 1602-1609
16. Jones H.A., Marino P.S., Shakur B.H., et al. In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J 21 (2003) 567-573
17. Chen D.L., Ferkol T.W., Mintun M.A., et al. Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am J Respir Crit Care Med 173 (2006) 1363-1369
18. 18F]-fluorodeoxyglucose uptake response in irradiated lung. Int J Radiat Oncol Biol Phys 68 (2007) 1030-1035
19. Hart J.P., McCurdy M.R., Ezhil M., et al. Radiation pneumonitis: correlation of toxicity with pulmonary metabolic radiation response. Int J Radiat Oncol Biol Phys 71 (2008) 967-971
20. Ajani J.A., Komaki R., Putnam J.B., et al. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer 92 (2001) 279-286
21. Liao Z., Liu H., and Komaki R. Target delineation for esophageal cancer. J Womens Imaging 5 (2003) 177-186
22. Vedam S.S., Keall P.J., Kini V.R., et al. Acquiring a four-dimensional computed tomography dataset using an external respiratory signal. Phys Med Biol 48 (2003) 45-62
23. Pan T., Lee T.Y., Rietzel E., et al. 4D-CT imaging of a volume influenced by respiratory motion on multi-slice CT. Med Phys 31 (2004) 333-340
24. Pan T., Mawlawi O., Luo D., et al. Attenuation correction of PET cardiac data with low-dose average CT in PET/CT. Med Phys 33 (2006) 3931-3938
25. Ahnesjo A. Collapsed cone convolution of radiant energy for photon dose calculation in heterogeneous media. Med Phys 16 (1989) 577-592
26. Studholme C., Hawkes D.J., and Hill D.L.G. A normalised entropy measure for multi-modality image alignment. Proc SPIE Med Imaging 3338 (1998) 132-142
27. Hu S., Hoffman E.A., and Reinhardt J.M. Automatic lung segmentation for accurate quantitation of volumetric X-ray CT images. IEEE Trans Med Imaging 20 (2001) 490-498
28. Strauss L.G., and Conti P.S. The applications of PET in clinical oncology. J Nucl Med 32 (1991) 623-648
29. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
30. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
31. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
32. Kruskal W.H., and Wallis W.A. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 47 (1952) 583-621
33. American Joint Committee on Cancer. AJCC staging manual. 6th ed. (2002), Lippincott-Raven Press, Philadelphia
34. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 28 (1994) 575-581
35. Pallarés C., Capdevila J., Paredes A., et al. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: A phase II trial. Lung Cancer 58 (2007) 238-245
36. Schweitzer V.G., Juillard G.J.F., Bajada C.L., et al. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel. Cancer 76 (1995) 1069-1072
37. Wong P., Leung A.N., Berry G.J., et al. Paclitaxel-induced hypersensitivity pneumonitis: Radiographic and CT findings. AJR Am J Roentgenol 176 (2001) 718-720
38. Shitara K., Ishii E., Kondo M., et al. Suspected paclitaxel-induced pneumonitis. Gastric Cancer 9 (2006) 325-328
39. Read W.L., Mortimer J.E., and Picus J. Severe interstitial pneumonitis associated with docetaxel administration. Cancer 94 (2002) 847-853
40. 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute trials. J Nucl Med 47 (2006) 1059-1066